Skip to main content
Year archive

Ascelia Pharma — 2023 filings

All 34 regulatory filings released by Ascelia Pharma (ACE) in 2023, sourced directly from the official regulator.

34 Filings
2023 Period
2023 filings (34)
Filing Released Lang
Major Shareholding Notification 2023
Major Shareholding Notification
2023-12-06 English
Ändring av antalet aktier och röster i Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2023-11-30 Swedish
Change in Number of Shares and Votes in Ascelia Pharma AB
Share Issue/Capital Change
2023-11-30 English
Bulletin from the Extraordinary General Meeting in Ascelia Pharma AB on 13 November 2023
AGM Information
2023-11-13 English
Kommuniké från extra bolagsstämma den 13 november 2023 i Ascelia Pharma AB
Capital/Financing Update
2023-11-13 Swedish
Ascelia Pharma beslutar om omvandling av C-aktier till stamaktier för leverans till deltagare i incitaments-program
Share Issue/Capital Change
2023-11-09 Swedish
Ascelia Pharma resolves on conversion of series C shares into ordinary shares for delivery to participants in incentive program
Share Issue/Capital Change
2023-11-09 English
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-08 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-08 English
NOTICE OF EXTRAORDINARY GENERAL MEETING IN ASCELIA PHARMA AB
Proxy Solicitation & Information Statement
2023-10-19 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I ASCELIA PHARMA AB
AGM Information
2023-10-19 Swedish
Ascelia Pharma significantly reduces organization to reach SPARKLE headline results
Board/Management Information
2023-08-31 English
Ascelia Pharma gör omfattande neddragning av organisationen för att nå headline-resultat med SPARKLE
Board/Management Information
2023-08-31 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-18 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-18 English
Ny utläsning krävs efter intraläsarinkonsistens rörande poängsättning av bilder av läsare från fas 3-studien SPARKLE
Legal Proceedings Report
2023-08-07 Swedish
Re-Evaluation Required After Intra-Reader Inconsistency in Scoring of Images from Phase 3 Study SPARKLE
Legal Proceedings Report
2023-08-07 English
Vid ESGARs årsmöte 2023 presenterade Ascelia Pharma Orviglance-data från studien med nedsatt leverfunktion samt var värd för en Q&A med experter inom leveravbildning
Legal Proceedings Report
2023-06-16 Swedish
Ascelia Pharma presented Orviglance Hepatic Impairment Data and hosted a Q&A with liver imaging experts at the 2023 ESGAR Annual Meeting
Regulatory Filings
2023-06-16 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-11 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-11 English
Kommuniké från årsstämma den 4 maj 2023 i Ascelia Pharma AB
AGM Information
2023-05-04 Swedish
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2023
AGM Information
2023-05-04 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-13 Swedish
KALLELSE TILL ÅRSSTÄMMA I ASCELIA PHARMA AB
AGM Information
2023-04-03 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
AGM Information
2023-04-03 English
Ascelia Pharma Mourns the Passing of Board Member René Spogárd
Board/Management Information
2023-03-13 English
Ascelia Pharma sörjer styrelseledamot René Spogárds bortgång
Board/Management Information
2023-03-13 Swedish
Change in number of shares and votes in Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2023-02-28 English
Ändring av antalet aktier och röster i Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2023-02-28 Swedish
Ascelia Pharma resolves on conversion of series C shares into ordinary shares for delivery to participants in incentive program
Remuneration Information
2023-02-21 English
Ascelia Pharma beslutar om omvandling av C-aktier till stamaktier för leverans till deltagare i incitamentsprogram
Share Issue/Capital Change
2023-02-21 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report FY 2022
2023-02-10 Swedish
Annual Report 2022
Annual Report FY 2022
2023-02-10 English